Intrauterine Contraceptive Devices Market Size

Global Intrauterine Contraceptive Devices Market size was valued at USD 4.4 billion in 2023 and is poised to grow from USD 4.6 billion in 2024 to USD 6.6 billion by 2032, growing at a CAGR of 4.6% during the forecast period (2025-2032).

The Intrauterine Contraceptive Devices (IUDs) market has expanded immensely over the last decade as a result of increased awareness of family planning and reproductive health. IUDs are among the most effective and longest-standing methods of contraception, and growing popularity for effectiveness and low maintenance requirements. IUDs placed in the uterus offer extended protection against pregnancy without the requirement of daily intervention. IUDs have emerged as an economic and risk-free option, resulting in increased usage by women of all segments. Increased emphasis on maternal health and the impetus provided by the government in the area of family planning are some of the key market growth drivers. Increased demand for convenience-based and hormone-free contraceptives will make the IUD market larger. The technology improvement, with the presence of new products centered on ease of use, has boosted the need for IUDs. Multiple drivers are behind the growth in the IUD market.

There is increased birth planning and control awareness, one of the driving forces. Governments, NGOs, and health organizations have helped promote awareness among individuals about the existence and benefits of IUDs. Further, intense demand for long-term birth control and increasing participation of women in the labor market have boosted expansion. IUDs provide women with the privilege of being secure without doing anything else in terms of a day-to-day activity and therefore are a preference for busy individuals. Market growth has also been triggered by the development of non-hormonal IUDs, which have been in high demand among women who want alternatives to hormonal products that may cause side effects. Faster growth in emerging economies because of increased emphasis on reproductive health has also opened new avenues for growth. With more women in developing countries having access to healthcare services, the use of IUDs will also increase, thereby propelling the market further. There are numerous advantages of IUDs with some limitations to market growth.

The primary limitations are cultural and social taboo regarding contraceptive products in some regions. In some communities, resistance in the adoption of IUDs has been seen because of myths based on safety and side effects, hence hindering adoption. Furthermore, the invasive nature of IUD insertion, although less hazardous, is avoided by some women who prefer to adopt other methods. The process is painful, uncomfortable, or may result in complications such as infection that would discourage one from adopting IUDs. Also, the cost of IUDs and insertion may be extremely high in poor areas and therefore cannot be reached by everyone. Although there are challenges within the healthcare sector that fight such challenges, there are still economic and cultural hurdles. In addition, the fact that other contraceptive types like oral contraceptives and condoms are available that are deemed less invasive and easily accessible poses a competition for IUDs' market since such restricts its growth potential within some niches.

How is Artificial Intelligence is revolutionizing the Intrauterine Contraceptive Devices (IUD)?

Artificial Intelligence (AI) is transforming the Intrauterine Contraceptive Devices (IUD) market into making the process more personalized and convenient. AI-powered systems analyze individual health information—i.e., medical history, hormone levels, and lifestyle—and suggest the most appropriate type of IUD, whether hormonal or non-hormonal. The tailored model addresses the various needs of women, providing the maximum level of contraceptive effectiveness with the lowest level of side effects. AI is also making virtual health assistants and online consultations possible and thereby reproductive healthcare more accessible, particularly among marginalized populations. AI is thus not only enhancing the precision of contraceptive decisions but also ensuring equal access to reproductive health care. For example,

The greatest achievement is the development of AI-based genetic testing websites, like Pexxi, which enable women to choose the best hormonal contraceptive based on their individual hormonal and genetic profile. The strategy is to reduce the trial-and-error process in searching for a birth control capable of reducing adverse effects.